Masaru Matsuda, See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 2,550 shares at $27.95 ($72K) on 2025-11-19, disclosed to the SEC on 2025-11-21.
Seasonal sale ($72k) by See Remarks — this insider has traded ARQT in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.95 | 989 | $28K | 38.3% |
| 2 | $28.50 | 1,561 | $44K | 61.7% |
| Total | $28.29 avg | 2,550 | $72K | 100% |
| Filing → |
| ARQT | SELL | 2026-08-05 | $32K | — | Filing → |
| ARQT | SELL | 2026-05-06 | $192K | — | Filing → |
| ARQT | SELL | 2026-03-03 | $314K | — | Filing → |